Reduced effectiveness of antibiotics in the treatment of general infection in children
In a study published in the leading medical magazine “Lancet”, it was found that medication for the treatment of general infections in children and infants is no longer effective in large parts of the world, due to the high rate of the resistance rate of bacteria for antibiotics. The study led by the University of Sydney said that many antibiotics recommended by the World Health Organization were less than 50% in the treatment of children’s infections such as pneumonia, bloodstream infections and meningitis. The results show that global guidelines on the use of antibiotics “are old and must be updated. The World Health Organization has announced that bacteria against antibiotics, one of the ten largest global health threats facing humanity. of the consequences of the consequences of the effects of the effects of the effects of the effects of the effects of the effects of antibiotics and other antimicetic medicines, which resist other words, against the effects of the effects of antibiotics and other antimicetic medicines, which withstand other words. does not respond or respond to the medication designed to kill or hinder their growth. Indonesia and the Philippines, where thousands of unnecessary deaths occur annually among children due to antibiotic resistance. These results add new evidence to the growing evidence that the general bacteria responsible for infections and meningitis in children are often resistant to prescribed antibiotics. The search for the urgent need to update the global antibiotics guidelines reveals the rapid development rates to withstand antimicrobial agents. The World Health Organization published the latest guidelines in this regard in 2013. The study found that one of the antibiotics, especially “Seftriaxon”, is likely to be effective in treating only one in every 3 cases of bloodstream infections or meningitis in newborns. Ceftriaxon is widely used in most parts of the world to treat many infections in children, such as pneumonia and urinary tract infections. Another antibiotic, ‘Gantamicin’, is likely to be effective in treating less than half of all cases of bloodstream infections and meningitis in children. ‘Gentamycin’ is usually described together with another antibiotic named ‘Aminopinslin’, which also showed the study that its effectiveness is low to combat bloodstream infections in infants and children. Antimicrobial resistance is a problem for children more than adults, as the possibility of trying to reduce and making new antibiotics for children decreases. The researchers say that the study “should be an invitation to wake up to the whole world.” The study analyzed 6648 bacterial samples from 11 countries through 86 studies to review the antibiotic sensitivity of the usual bacteria that cause the infection of children. The researchers said that the best way to treat antibiotic resistance in infections in children is to finance research in new antibiotic treatments for children and priority of newborns.